BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 30180843)

  • 1. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin.
    Dai B; Li H; Fan J; Zhao Y; Yin Z; Nie X; Wang DW; Chen C
    Cardiovasc Diabetol; 2018 Sep; 17(1):123. PubMed ID: 30180843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction.
    Prakoso D; De Blasio MJ; Qin C; Rosli S; Kiriazis H; Qian H; Du XJ; Weeks KL; Gregorevic P; McMullen JR; Ritchie RH
    Clin Sci (Lond); 2017 Jun; 131(12):1345-1360. PubMed ID: 28487469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
    Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH
    Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
    Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
    Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits.
    Zhang X; Zhang Z; Yang Y; Suo Y; Liu R; Qiu J; Zhao Y; Jiang N; Liu C; Tse G; Li G; Liu T
    Cardiovasc Diabetol; 2018 Dec; 17(1):160. PubMed ID: 30591063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Na+/Ca2+ exchanger-1 protects against systolic failure in the Akitains2 model of diabetic cardiomyopathy via a CXCR4/NF-κB pathway.
    LaRocca TJ; Fabris F; Chen J; Benhayon D; Zhang S; McCollum L; Schecter AD; Cheung JY; Sobie EA; Hajjar RJ; Lebeche D
    Am J Physiol Heart Circ Physiol; 2012 Aug; 303(3):H353-67. PubMed ID: 22610174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart.
    Xie SY; Liu SQ; Zhang T; Shi WK; Xing Y; Fang WX; Zhang M; Chen MY; Xu SC; Fan MQ; Li LL; Zhang H; Zhao N; Zeng ZX; Chen S; Zeng XF; Deng W; Tang QZ
    Circulation; 2024 Feb; 149(9):684-706. PubMed ID: 37994595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα.
    Yin Z; Zhao Y; He M; Li H; Fan J; Nie X; Yan M; Chen C; Wang DW
    Cardiovasc Diabetol; 2019 Jan; 18(1):7. PubMed ID: 30635067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.
    Biernacka A; Cavalera M; Wang J; Russo I; Shinde A; Kong P; Gonzalez-Quesada C; Rai V; Dobaczewski M; Lee DW; Wang XF; Frangogiannis NG
    Circ Heart Fail; 2015 Jul; 8(4):788-98. PubMed ID: 25985794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling.
    Gao L; Liu Y; Guo S; Xiao L; Wu L; Wang Z; Liang C; Yao R; Zhang Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3322-3338. PubMed ID: 30031228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium.
    Rawal S; Nagesh PT; Coffey S; Van Hout I; Galvin IF; Bunton RW; Davis P; Williams MJA; Katare R
    Cardiovasc Diabetol; 2019 Jan; 18(1):13. PubMed ID: 30696455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of miR-22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1.
    Tang Q; Len Q; Liu Z; Wang W
    Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29288528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.
    Arow M; Waldman M; Yadin D; Nudelman V; Shainberg A; Abraham NG; Freimark D; Kornowski R; Aravot D; Hochhauser E; Arad M
    Cardiovasc Diabetol; 2020 Jan; 19(1):7. PubMed ID: 31924211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-340-5p Mediates Cardiomyocyte Oxidative Stress in Diabetes-Induced Cardiac Dysfunction by Targeting Mcl-1.
    Zhu Y; Yang X; Zhou J; Chen L; Zuo P; Chen L; Jiang L; Li T; Wang D; Xu Y; Li Q; Yan Y
    Oxid Med Cell Longev; 2022; 2022():3182931. PubMed ID: 35126811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear miR-320 Mediates Diabetes-Induced Cardiac Dysfunction by Activating Transcription of Fatty Acid Metabolic Genes to Cause Lipotoxicity in the Heart.
    Li H; Fan J; Zhao Y; Zhang X; Dai B; Zhan J; Yin Z; Nie X; Fu XD; Chen C; Wang DW
    Circ Res; 2019 Dec; 125(12):1106-1120. PubMed ID: 31638474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight fucoidan alleviates cardiac dysfunction in diabetic Goto-Kakizaki rats by reducing oxidative stress and cardiomyocyte apoptosis.
    Yu X; Zhang Q; Cui W; Zeng Z; Yang W; Zhang C; Zhao H; Gao W; Wang X; Luo D
    J Diabetes Res; 2014; 2014():420929. PubMed ID: 25525607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MALAT1-mediated recruitment of the histone methyltransferase EZH2 to the microRNA-22 promoter leads to cardiomyocyte apoptosis in diabetic cardiomyopathy.
    Wang C; Liu G; Yang H; Guo S; Wang H; Dong Z; Li X; Bai Y; Cheng Y
    Sci Total Environ; 2021 Apr; 766():142191. PubMed ID: 33097254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy.
    Li X; Du N; Zhang Q; Li J; Chen X; Liu X; Hu Y; Qin W; Shen N; Xu C; Fang Z; Wei Y; Wang R; Du Z; Zhang Y; Lu Y
    Cell Death Dis; 2014 Oct; 5(10):e1479. PubMed ID: 25341033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrine pretreatment improves cardiac function in rats with diabetic cardiomyopathy via suppressing ROS/TLR-4 signaling pathway.
    Liu ZW; Wang JK; Qiu C; Guan GC; Liu XH; Li SJ; Deng ZR
    Acta Pharmacol Sin; 2015 Mar; 36(3):323-33. PubMed ID: 25619390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
    Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
    Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.